Voyager Therapeutics, Inc.
VYGR· Nasdaq
VYGRVoyager Therapeutics, Inc.
Filed Mar 17, 2016 · 10-K · 77 days after period end · 0001558370-16-004222
| Metric | Q4 2015 | Q4 2014 |
|---|---|---|
| Revenue | $4.94M | — |
| Net Income | -$7.28M | — |
| EPS Diluted | $0.67 | $6.58 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Voyager Therapeutics, Inc. · CIK 1640266 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 17, 2016 · 77 d after period end
